Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inflazyme and HMR to collaborate on allergy, asthma and respiratory disease therapies

Feb. 10, 1999

Picroliv now reported to possess promising antiallergic activity

Feb. 9, 1999

Byk Gulden's roflumilast in clinical trials; spotlight on PDE4 inhibitors for asthma

Feb. 9, 1999

Antiallergic/antiasthmatic agents from Kaken acting specifically on eosinophils

Feb. 9, 1999

Discovery's Surfaxin shows positive phase II results in MAS

Feb. 9, 1999

Purinoceptor P2 receptor antagonists in early development at Astra

Feb. 8, 1999

Successful phase II trial of chronic bronchitis treatment reported by Milkhaus

Feb. 5, 1999

Novel mast cell inhibitor tested preclinically for allergy prevention

Feb. 5, 1999

Schering-Plough seeks approval for pediatric use of Nasonex nasal spray

Feb. 4, 1999

Grant to be used to study effect of P-113 in chronic lung infections

Feb. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...